✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ind-Swift Laboratories Ltd.

INDSWFTLAB

Market Cap
₹770 Cr.
P/E
3.21

Ind-Swift Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
770 Cr
PE
PE
3.21
Prom Holding
Prom Holding
40.94 %
ROE (%)
ROE (%)
45.19
ROCE (%)
ROCE (%)
27.00
Div Yield (%)
Div Yield (%)
-
Sales
Sales
447 Cr
OPM (%)
OPM (%)
-16.41 %
Debt to Equity
Debt to Equity
0.01
View more
Edit Ratio's
About
Ind-Swift Laboratories Ltd, a public limited company established in 1995, is a global manufact… Read more
Low
69
52W Range
High
186
  • Ind-Swift Lab.
  • Prevest Denpro
  • Kilitch Drugs(India)

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
10 %
(as of Mar 20)
Source/Historic
Atorvastatin (Digestive) - Market Share
25 %
(as of Mar 20)
Source/Historic
Clarithromycin (Respiratory) - Market Share
15 %
(as of Mar 20)
Source/Historic
Clopidogrel (Cardio) - Market Share
8 %
(as of Mar 20)
Source/Historic
Ezetimibe (Cardio) - Market Share
20 %
(as of Mar 20)
Source/Historic
Fexofenadine (Anti-Allergic) - Market Share
25 %
(as of Mar 20)
Source/Historic
Ivabradine (Cardio) - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Total reactor capacity (kL)
      Source
    • DMF Filingsby API (.)
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    FAQs on Ind-Swift Laboratories Ltd. Business

    Ind-Swift Laboratories Ltd, based in Chandigarh, India, is a global manufacturer of APIs, Intermediates, and formulations. Established in 1995, the company focuses on API manufacturing and is a key player in the Indian pharmaceutical industry.

    Ind-Swift Lab. major competitors are Kilitch Drugs(India), Venus Remedies, Jenburkt Pharma, Sakar Healthcare, Prevest Denpro, Medicamen Biotech, Bharat Parenterals.
    Market Cap of Ind-Swift Lab. is ₹678 Crs.
    While the median market cap of its peers are ₹650 Crs.

    Ind-Swift Lab. seems to be less financially stable compared to its competitors.
    Altman Z score of Ind-Swift Lab. is 5.14 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar
    Investor Presentation Jun Sep
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material